Join Achieve TMS East to Celebrate the Grand Opening of its Andover Location
12 mars 2019 08h00 HE
|
BrainsWay Ltd.
ANDOVER, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression and...
BrainsWay Announces New Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder: – “BrainsWay OCD Launchpad to Success”
05 mars 2019 11h09 HE
|
BrainsWay Ltd.
HACKENSACK, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN), the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain...
BrainsWay Expands Intellectual Property Position by Obtaining Rights to Multi-Channel Transcranial Magnetic Stimulation Patent Portfolio
05 mars 2019 08h30 HE
|
BrainsWay Ltd.
Acquires Multi-Channel TMS Patent Portfolio from TMS Innovations Enters into an Exclusive Option Agreement with Stanford University to License Additional Multi-Channel TMS Patents BrainsWay is...
BrainsWay Expands its Deep TMS Commercial Footprint into Asia Pacific
20 févr. 2019 08h00 HE
|
BrainsWay Ltd.
JERUSALEM, Feb. 20, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment of brain disorders, today announced that the Company has entered an...
Calabasas Behavioral Health and BrainsWay Host “After the Smoke Clears”
13 févr. 2019 08h00 HE
|
BrainsWay Ltd.
CALABASAS, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Calabasas Behavioral Health, a leading mental health service provider in Southern California, announced today that it is partnering with...
BrainsWay Receives PMDA Approval in Japan of Deep Transcranial Magnetic Stimulation System for Treatment of Major Depressive Disorder
29 janv. 2019 08h00 HE
|
BrainsWay Ltd.
JERUSALEM, Jan. 29, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN), a global leader in the advanced non-invasive treatment of brain disorders, today announced that its Deep TMS System has been...
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder
10 déc. 2018 07h00 HE
|
BrainsWay Ltd.
HACKENSACK, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (TASE: BRIN), the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain...
Brainsway Reports Financial Results for Third Quarter of 2018 and Provides Corporate Update
13 nov. 2018 08h00 HE
|
BrainsWay Ltd.
Third quarter revenues of $4.3 million represent quarterly record and 42% increase over third quarter 2017 Recently commenced installing Deep TMS system for treatment of OCD at U.S. Sites ...
BrainsWay to Showcase Deep Transcranial Magnetic Stimulation System for the Treatment of Obsessive-Compulsive Disorder at the 2018 Annual Psych Congress
17 oct. 2018 08h00 HE
|
BrainsWay Ltd.
Showcase represents the public debut of BrainsWay’s Deep TMS system for OCD Healthcare providers will be able to view demonstrations of and purchase the BrainsWay system and OCD helmet at conference...
BrainsWay Announces First Shipments of Deep Transcranial Magnetic Stimulation Helmets for the Treatment of Obsessive-Compulsive Disorder
08 oct. 2018 08h00 HE
|
BrainsWay Ltd.
Twenty sites across the U.S. are the first to receive the BrainsWay Deep transcranial magnetic stimulation system (Deep TMS) for obsessive-compulsive disorder (OCD) HACKENSACK, N.J., Oct. 08, 2018 ...